Items without sitelinks

Jump to navigation Jump to search

Showing below up to 50 results in range #451 to #500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. long-chain-alcohol O-fatty-acyltransferase activity (Q22052)
  2. wax ester (Q22051)
  3. wax monoester (Q22050)
  4. list of omega-3 fatty acids (Q22046)
  5. Essential fatty acid interactions (Q22045)
  6. long-chain fatty acid metabolic process (Q22044)
  7. long-chain fatty acid biosynthetic process (Q22043)
  8. long-chain fatty acid import across plasma membrane (Q22042)
  9. wide pore channel activity (Q22041)
  10. porin activity (Q22040)
  11. long-chain fatty acid transporting porin activity (Q22039)
  12. peroxisomal transport (Q22038)
  13. peroxisomal membrane transport (Q22037)
  14. long-chain fatty acid import into peroxisome (Q22036)
  15. long-chain fatty acid transporter activity (Q22035)
  16. long-chain fatty acid transport (Q22034)
  17. long-chain fatty acid import into cell (Q22033)
  18. long chain fatty acid (Q22032)
  19. list of unsaturated fatty acids (Q22031)
  20. unsaturated fatty acid metabolic process (Q22030)
  21. unsaturated fatty acid biosynthetic process (Q22029)
  22. unsaturated fatty acids (Q22028)
  23. vitamin D4 metabolic process (Q22020)
  24. 24,25,26,27-tetranor-9,10-secocholestane steroid (Q22018)
  25. secondary hyperparathyroidism (Q22016)
  26. secondary hyperparathyroidism of renal origin (Q22015)
  27. rare genetic parathyroid disease and phosphocalcic metabolism disorder (Q22014)
  28. rare genetic bone disease (Q22013)
  29. rare genetic bone development disorder (Q22012)
  30. primary bone dysplasia (Q22011)
  31. primary bone dysplasia with defective bone mineralization (Q22010)
  32. rare parathyroid disease and phosphocalcic metabolism anomaly (Q22009)
  33. disorders of vitamin D metabolism (Q22008)
  34. vitamin D deficiency (Q22007)
  35. metabolic bone disease (Q22006)
  36. (23S)-23,25-dihydroxycalciol (Q22005)
  37. 25-hydroxycholecalciferol-23-hydroxylase activity (Q22004)
  38. vasoconstriction (Q22003)
  39. vasoconstrictor agents (Q22002)
  40. calcium channel agonists (Q22001)
  41. autoimmune skin disease (Q22000)
  42. psoriasis (Q21999)
  43. antipsoriatic (Q21998)
  44. hyperparathyroidism (Q21997)
  45. vitamin D 23-hydroxylase activity (Q21996)
  46. 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity (Q21995)
  47. calcitriol binding (Q21994)
  48. calcidiol 1-monooxygenase activity (Q21992)
  49. calcidiol binding (Q21991)
  50. swelling (Q21989)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://wiki.tiffa.net/wiki/Special:ItemsWithoutSitelinks"